Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Etiler, Ankara, Turkey.
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Etiler, Ankara, Turkey.
J Ethnopharmacol. 2020 Feb 10;248:112322. doi: 10.1016/j.jep.2019.112322. Epub 2019 Oct 20.
ETHNOPHARMACOLOGICAL RELEVANCE: The ethnobotanical studies conducted in Turkey and other countries have revealed that Cornus mas L., from the family Cornaceae have been used against stomachache, diarrhea and colitis. AIM OF THE STUDY: The objective the present study is to determine the possible activity of C. mas in experimentally induced ulcerative colitis in rats and to identify its phytochemical feature. MATERIALS AND METHODS: 2,4,6-Trinitrobenzene sulfonic acid-induced colitis model was induced in rats. The rats were orally treated with different doses (50, 100, 200 and 400 mg/kg) of C. mas 80% methanol extract for 14 days. Increase in body weight, consumed amount of feed, form of the stool, presence of rectal prolapse were followed every day. At the end of the experiment, colon tissues were removed and wet weights for each animal were measured and colon damages were scored. Total antioxidant and total oxidant status, cytokine (TNF-α and IL-1β) and protein levels of colon tissues were evaluated and histopathological analyses were carried out. After the detection of the effective dose as 400 mg/kg, the aqueous methanol extract was fractionated by using liquid-liquid fractionation technique and the sub-extracts were also tested for in vivo biological activities. High Performance Liquid Chromatography analyses were conducted to determine the phytochemical profile of the active crude extract and n-butanol sub-extract. RESULTS: Amount of feed consumed per day and increase in body weight were the lowest in the control group, while those values were determined to be the highest in 80% methanol extract (at 400 mg/kg dose), n-butanol sub-extract and reference groups. Following colitis induction, it was determined that the fecal form was yellow-slippery in all groups and returned to normal after the treatment with C. mas extracts. Rectal prolapse score was less in the extract (400 mg/kg) and n-butanol sub-extract treated groups. Total antioxidant, total oxidant status, cytokine and protein levels were found to be in parallel with macroscopic findings. 80% methanol extract (400 mg/kg) and n-butanol sub-extract provided the best healing according to the wet weight measurements and colon damage scoring performed on the removed colon tissues. These findings supported the results of histopathological analysis. According to the chromatographic analysis, ellagic acid was determined in both extracts and its amount was quantified. CONCLUSIONS: The present study has verified the ethnomedical use of C. mas for the treatment of ulcerative colitis.
民族药理学相关性:在土耳其和其他国家进行的民族植物学研究表明,山茱萸科的山茱萸已被用于治疗胃痛、腹泻和结肠炎。
研究目的:本研究的目的是确定实验性溃疡性结肠炎模型中 C. mas 的可能活性,并鉴定其植物化学特征。
材料和方法:采用 2,4,6-三硝基苯磺酸诱导大鼠结肠炎模型。大鼠连续 14 天经口给予不同剂量(50、100、200 和 400mg/kg)80%甲醇提取物。每天观察体重增加、饲料消耗、粪便形态、直肠脱垂情况。实验结束时,取出结肠组织,测量每只动物的湿重并对结肠损伤进行评分。评估结肠组织的总抗氧化和总氧化状态、细胞因子(TNF-α和 IL-1β)和蛋白质水平,并进行组织病理学分析。检测到有效剂量为 400mg/kg 后,用液-液萃取技术对水-甲醇提取物进行分段,并用亚提取物进行体内生物活性测试。进行高效液相色谱分析以确定活性粗提取物和正丁醇亚提取物的植物化学特征。
结果:对照组每天的饲料消耗量和体重增加最低,而 80%甲醇提取物(400mg/kg 剂量)、正丁醇亚提取物和参比组的这些值最高。结肠炎诱导后,所有组的粪便形态均为黄色滑溜,用 C. mas 提取物治疗后恢复正常。提取物(400mg/kg)和正丁醇亚提取物处理组的直肠脱垂评分较低。总抗氧化、总氧化状态、细胞因子和蛋白质水平与宏观发现平行。根据对切除的结肠组织进行的湿重测量和结肠损伤评分,80%甲醇提取物(400mg/kg)和正丁醇亚提取物提供了最佳的愈合效果。这些发现支持组织病理学分析的结果。根据色谱分析,在两种提取物中均检测到鞣花酸,并对其含量进行了定量。
结论:本研究验证了山茱萸科植物在治疗溃疡性结肠炎方面的民族医学用途。
World J Gastroenterol. 2014-11-7
Evid Based Complement Alternat Med. 2021-12-28
Int J Nanomedicine. 2020-6-3